Practical guide to exocrine pancreatic insufficiency – Breaking the myths
暂无分享,去创建一个
[1] J. Murray,et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. , 2003, Archives of internal medicine.
[2] F. Guarner,et al. Fate of oral enzymes in pancreatic insufficiency. , 1993, Gut.
[3] A. Huebner,et al. Pancreatic Elastase 1 in Feces of Preterm and Term Infants , 2001, Journal of pediatric gastroenterology and nutrition.
[4] M. Wilschanski,et al. Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[5] U. Fölsch,et al. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. , 1996, Gut.
[6] P. Lankisch. [Chronic pancreatitis]. , 1991, Der Internist.
[7] D. Meyerholz,et al. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[8] C. V. van Eijck,et al. A Prospective Assessment of the Natural Course of the Exocrine Pancreatic Function in Patients With a Pancreatic Head Tumor , 2013, Journal of clinical gastroenterology.
[9] D. Theriaque,et al. Ranitidine and Omeprazole as Adjuvant Therapy to Pancrelipase to Improve Fat Absorption in Patients With Cystic Fibrosis , 2002, Journal of pediatric gastroenterology and nutrition.
[10] E. Dimagno,et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. , 1994, Gastroenterology.
[11] M. Corey,et al. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. , 1988, Journal of clinical epidemiology.
[12] M. Corey,et al. Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis. , 2005, The Journal of pediatrics.
[13] Dhiraj Yadav,et al. The epidemiology of pancreatitis and pancreatic cancer. , 2013, Gastroenterology.
[14] R. Hubbard,et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England , 2003, Gut.
[15] J. Iglesias-Garcia,et al. The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[16] S. Caras,et al. Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial , 2010, The American Journal of Gastroenterology.
[17] P. Durie,et al. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. , 1995, The Journal of pediatrics.
[18] J. Lieb,et al. Pancreatic function testing: here to stay for the 21st century. , 2008, World journal of gastroenterology.
[19] L. Traverso,et al. Exocrine function following the whipple operation as assessed by stool elastase , 2006, Journal of Gastrointestinal Surgery.
[20] J. Dijkman,et al. Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas , 2005, Digestive Diseases and Sciences.
[21] J. Semler,et al. Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule , 2013, Digestive Diseases and Sciences.
[22] A. Andriulli,et al. Italian consensus guidelines for chronic pancreatitis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[23] L. Gullo,et al. Quality of life in patients with chronic pancreatitis. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[24] E. Kuipers,et al. Pancreatic enzyme replacement therapy in chronic pancreatitis. , 2010, Best practice & research. Clinical gastroenterology.
[25] M. Bardella,et al. Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease , 1999, American Journal of Gastroenterology.
[26] S. Barreto,et al. The islet-acinar axis of the pancreas: more than just insulin. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[27] D. Graham,et al. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century. , 2014, World journal of gastroenterology.
[28] G. Cont,et al. Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease , 2014, Journal of clinical gastroenterology.
[29] P. Lewindon,et al. Cystic fibrosis: An update for clinicians. Part 2: Hepatobiliary and pancreatic manifestations , 2014, Journal of gastroenterology and hepatology.
[30] E. Kuipers,et al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[31] J. Domínguez-Muñoz,et al. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it? , 2011, Advances in medical sciences.
[32] M. Falconi,et al. Pancreatic insufficiency after different resections for benign tumours , 2007, The British journal of surgery.
[33] D. Conwell,et al. Pathogenesis of Chronic Pancreatitis: An Evidence-Based Review of Past Theories and Recent Developments , 2004, The American Journal of Gastroenterology.
[34] J. Keller,et al. Human pancreatic exocrine response to nutrients in health and disease , 2005, Gut.
[35] G. Adler,et al. Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis , 1996, European journal of gastroenterology & hepatology.
[36] J. Meyer,et al. Mismatch of Duodenal Deliveries of Dietary Fat and Pancreatin from Enterically Coated Microspheres , 1997, Pancreas.
[37] C. Sempoux,et al. Persistent decreased plasma cholecystokinin levels in celiac patients under gluten-free diet: respective roles of histological changes and nutrient hydrolysis , 2002, Regulatory Peptides.
[38] A. Ruzzenente,et al. Systematic review of central pancreatectomy and meta‐analysis of central versus distal pancreatectomy , 2013, The British journal of surgery.
[39] Melissa R. Miller,et al. Evidence for a Causal Relationship Between Early Exocrine Pancreatic Disease and Cystic Fibrosis–Related Diabetes: A Mendelian Randomization Study , 2014, Diabetes.
[40] J. Neoptolemos,et al. Exocrine Pancreatic Function following Pancreatectomy , 1999, Annals of the New York Academy of Sciences.
[41] S. Ng,et al. Drug therapies for reducing gastric acidity in people with cystic fibrosis. , 2016, The Cochrane database of systematic reviews.
[42] S. Chari,et al. International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas , 2006, Pancreatology.
[43] L. Gullo,et al. Fecal Elastase 1 Determination in Chronic Pancreatitis , 2004, Digestive Diseases and Sciences.
[44] J. Neoptolemos,et al. Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study , 2011, Pancreatology.
[45] P. Hardt,et al. Exocrine Pancreatic Insufficiency in Diabetes Mellitus: A Complication of Diabetic Neuropathy or a Different Type of Diabetes? , 2011, Experimental diabetes research.
[46] D. Linder,et al. Elastase 1 and chymotrypsin B in pancreatic juice and feces. , 1989, Clinical biochemistry.
[47] W. Uhl,et al. Early and late postoperative changes in the quality of life after pancreatic surgery , 2013, Langenbeck's Archives of Surgery.
[48] E. Dimagno,et al. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. , 1977, The New England journal of medicine.
[49] A. Bross,et al. Duodenal Secretion and Fecal Excretion of Pancreatic Elastase‐1 in Healthy Humans and Patients with Chronic Pancreatitis , 1997, Pancreas.
[50] E. Lebenthal,et al. Development of functional responses in human exocrine pancreas. , 1980, Pediatrics.
[51] R. Houwen,et al. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis , 2015, Journal of pediatric gastroenterology and nutrition.
[52] J. Iglesias-Garcia,et al. The Spanish Pancreatic Club recommendations for the diagnosis and treatment of chronic pancreatitis: part 1 (diagnosis). , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[53] A. Berry. Pancreatic enzyme replacement therapy during pancreatic insufficiency. , 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[54] M. McAlindon,et al. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? , 2006, Alimentary pharmacology & therapeutics.
[55] J. Barkin,et al. Enzyme Content and Acid Stability of Enteric-Coated Pancreatic Enzyme Products In Vitro , 2005, Pancreas.
[56] S. Freedman,et al. Factors Determining Optimal Fatty Acid Absorption in Preterm Infants , 2016, Journal of pediatric gastroenterology and nutrition.
[57] E. Kuipers,et al. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey. , 2012, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[58] H. Witt,et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. , 2007, Gastroenterology.
[59] B. Wilcken,et al. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program. , 1990, The New England journal of medicine.
[60] M. Armand,et al. Enzyme replacement therapy for pancreatic insufficiency: present and future , 2011, Clinical and experimental gastroenterology.
[61] L. Traverso,et al. Pancreatic Exocrine Function Is Preserved After Distal Pancreatectomy , 2010, Journal of Gastrointestinal Surgery.
[62] R. Laugier,et al. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability , 2007, Alimentary pharmacology & therapeutics.
[63] M. Corey,et al. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? , 2002, The Journal of pediatrics.
[64] J. Lloyd-Still,et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. , 1997, The New England journal of medicine.
[65] M. Raimondo,et al. Pancreatic Enzyme Pharmacotherapy , 2007, Pharmacotherapy.
[66] M. Phillips. Pancreatic exocrine insufficiency following pancreatic resection. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[67] D. Adams,et al. Operative management of chronic pancreatitis: longterm results in 372 patients. , 2007, Journal of the American College of Surgeons.
[68] A. Stecenko,et al. Clinical Pharmacology of Pancreatic Enzymes in Patients with Cystic Fibrosis and In Vitro Performance of Microencapsulated Formulations , 1994, Journal of clinical pharmacology.
[69] A. Figueiras,et al. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three‐way crossover study , 2005, Alimentary pharmacology & therapeutics.
[70] J. Singh,et al. Mechanism of exocrine pancreatic insufficiency in streptozotocin-induced diabetes mellitus in rat: Effect of cholecystokinin-octapeptide , 2004, Molecular and Cellular Biochemistry.
[71] M. Löhr,et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency , 1998, Gut.
[72] E. Dimagno,et al. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. , 1973, The New England journal of medicine.
[73] T. Stevens,et al. Cigarette Smoking Is Independently Associated with Chronic Pancreatitis , 2010, Pancreatology.
[74] R. Bretzel,et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) , 2007, Diabetes/metabolism research and reviews.
[75] J. Hendriks,et al. Effects of a proton‐pump inhibitor in cystic fibrosis , 1998, Acta paediatrica.
[76] M. Kakei,et al. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency , 2012, Core evidence.
[77] B. Lindkvist. Diagnosis and treatment of pancreatic exocrine insufficiency. , 2013, World journal of gastroenterology.
[78] G. Capurso,et al. Exocrine Pancreatic Insufficiency in Diabetic Patients: Prevalence, Mechanisms, and Treatment , 2015, International journal of endocrinology.
[79] J. Windsor,et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[80] J. Lloyd-Still. Cystic fibrosis and colonic strictures. A new "iatrogenic" disease. , 1995, Journal of clinical gastroenterology.
[81] M. Proesmans,et al. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes , 2003, European Journal of Pediatrics.